marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Amicus Therapeutics Financial Ratios 2011-2024 | FOLD
Annual Financial Ratios Amicus Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-25.5 | -16.7 | -10.2 | -17.7 | -6.1 | -6.2 | -8.7 | -6.1 | -5.0 | -8.3 | -2.4 | -3.4 | -5.1 |
P/S |
9.7 | 12.0 | 8.4 | 18.8 | 12.0 | 23.8 | 66.6 | 246.0 | - | 467.7 | 399.8 | 9.1 | 10.5 |
EPS |
-0.5 | -0.8 | -0.9 | -1.1 | -1.5 | -1.9 | -1.9 | -1.5 | -1.2 | -0.9 | -1.2 | -1.1 | -1.3 |
EV (Enterprise Value) |
4.23 B | 4.4 B | 2.91 B | 5.33 B | 2.41 B | 2.54 B | 2.68 B | 1.03 B | 1.16 B | 636 M | 183 M | 174 M | 240 M |
EBITDA per Share |
-0.23 | -0.72 | -0.74 | -0.92 | -1.23 | -1.73 | -1.35 | -0.791 | -1.13 | -0.902 | -1.18 | -1.12 | -1.43 |
EV/EBITDA |
-14.0 | -21.8 | -7.4 | -7.5 | -12.4 | -6.8 | -5.1 | -8.4 | -1.9 | -2.6 | -4.1 | ||
PEG |
0.88 | 1.72 | -2.03 | -6.0 | -0.29 | 3.83 | 0.36 | -0.23 | 0.17 | -0.42 | 0.29 | -0.21 | -0.14 |
P/B |
24.1 | 32.1 | 8.3 | 17.1 | 4.6 | 6.3 | 7.0 | - | 1.9 | 4.7 | 3.2 | 2.4 | 7.6 |
P/CF |
-55.9 | -23.7 | -12.6 | -21.0 | -8.1 | -7.1 | -11.2 | -7.8 | -6.3 | -11.0 | -3.1 | -4.4 | -4.4 |
ROE % |
-94.64 | -192.26 | -81.49 | -96.67 | -74.80 | -101.77 | -80.49 | - | -37.98 | -56.41 | -130.34 | -70.48 | -150.08 |
ROA % |
-19.49 | -32.67 | -27.67 | -31.23 | -41.92 | -44.18 | -45.29 | - | -14.54 | -32.83 | -46.75 | -44.31 | -63.63 |
ROCE % |
-48.20 | -172.39 | -67.16 | -86.25 | -41.69 | -46.24 | -37.86 | - | -15.10 | -36.18 | -53.11 | -52.49 | -100.69 |
Current Ratio |
1.3 | 1.2 | 1.5 | 1.5 | 4.0 | 6.4 | 5.6 | - | 2.9 | 7.7 | 8.4 | 11.3 | 3.5 |
DSO |
70.3 | 65.9 | 59.5 | 56.1 | 66.7 | 87.9 | 93.5 | - | - | - | 763.2 | 63.9 | 85.9 |
DIO |
408.3 | 239.4 | 245.6 | 197.5 | 233.3 | 212.6 | 270.6 | - | - | - | - | - | - |
DPO |
149.3 | 174.6 | 204.3 | 228.0 | 361.0 | 167.4 | 460.5 | - | - | - | - | - | - |
Operating Cycle |
478.6 | 305.3 | 305.1 | 253.6 | 300.0 | 300.5 | 364.1 | - | - | - | - | - | - |
Cash Conversion Cycle |
329.3 | 130.7 | 100.8 | 25.6 | -61.0 | 133.1 | -96.3 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Amicus Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.02 | -0.05 | - | -0.07 | -0.15 | -0.18 | - | -0.12 | -0.21 | -0.3 | - | -0.19 | -0.19 | -0.25 | -0.27 | -0.25 | -0.2 | -0.35 | -0.35 | -0.24 | -0.36 | -0.56 | -0.43 | -0.84 | -0.33 | -0.28 | -0.42 | -0.69 | -0.34 | -0.39 | -0.41 | -0.33 | -0.4 | -0.35 | -0.34 | -0.32 | -0.27 | -0.25 | -0.24 | -0.22 | -0.22 | -0.25 | -0.22 | -0.29 | -0.31 | -0.35 | -0.2 | -0.34 | -0.2 | -0.35 | -0.25 | -0.28 | -0.37 | -0.39 |
EBITDA per Share |
0.08 | 0.06 | - | -0.05 | -0.06 | -0.12 | - | -0.11 | -0.2 | -0.26 | - | -0.15 | -0.14 | -0.19 | - | -0.19 | -0.19 | -0.3 | - | -0.22 | -0.32 | -0.38 | - | -0.82 | -0.24 | -0.31 | - | -1.71 | -0.32 | -0.36 | - | -0.31 | -0.37 | -0.34 | - | -0.32 | -0.27 | -0.25 | - | -0.21 | -0.21 | -0.24 | - | -0.3 | -0.31 | -0.34 | - | -0.34 | -0.19 | -0.27 | - | -0.36 | -0.41 | -0.28 |
ROE % |
-48.00 | -82.98 | -106.54 | -131.65 | -140.57 | -137.66 | -96.68 | -110.03 | -98.28 | -86.39 | -63.47 | -88.40 | -97.40 | -91.79 | -96.67 | -90.57 | -81.20 | -80.61 | -74.80 | -78.74 | -112.18 | -112.47 | -101.77 | -98.62 | -83.85 | -79.46 | -80.49 | -77.16 | -58.47 | -59.00 | -55.54 | -51.59 | -49.51 | -43.13 | -37.98 | -43.02 | -46.19 | -50.35 | -56.41 | -65.79 | -83.65 | -105.23 | -130.34 | -118.06 | -109.71 | -89.66 | -70.48 | -85.28 | -94.73 | -123.95 | -150.08 | -32.98 | -42.72 | -45.11 |
ROA % |
-8.60 | -13.66 | -16.30 | -20.68 | -22.24 | -26.63 | -25.00 | -30.26 | -20.82 | -27.33 | -19.87 | -27.93 | -29.89 | -29.30 | -31.23 | -33.73 | -33.78 | -37.80 | -41.92 | -41.25 | -54.13 | -52.01 | -44.18 | -45.33 | -42.99 | -42.84 | -45.29 | -39.91 | -26.60 | -23.85 | -19.29 | -18.36 | -18.02 | -16.08 | -14.54 | -19.93 | -23.93 | -27.91 | -32.83 | -32.31 | -35.58 | -40.66 | -46.75 | -46.25 | -49.61 | -46.07 | -44.31 | -47.63 | -46.81 | -56.44 | -63.63 | -13.98 | -18.11 | -19.13 |
ROCE % |
-2.15 | -31.16 | -66.37 | -91.90 | -104.65 | -122.70 | -92.05 | -103.31 | -89.04 | -72.24 | -50.56 | -68.98 | -76.15 | -75.92 | -63.61 | -75.64 | -69.24 | -67.36 | -45.13 | -90.68 | -124.19 | -121.84 | -75.62 | -153.62 | -186.07 | -185.73 | -106.08 | -118.56 | -53.03 | -53.18 | -37.90 | -48.83 | -47.29 | -41.56 | -25.60 | -39.36 | -42.19 | -46.12 | -38.23 | -71.31 | -90.62 | -113.93 | -105.77 | -130.21 | -121.57 | -100.09 | -53.46 | -97.85 | -117.79 | -154.05 | -127.93 | -44.38 | -49.76 | -33.79 |
Current Ratio |
1.3 | 1.2 | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | - | 1.4 | 1.5 | 1.6 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.5 | 2.3 | 2.3 | 2.3 | 2.3 | 1.8 | 1.8 | 1.8 | 1.8 | 2.3 | 2.3 | 2.3 | 2.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
59.1 | 62.2 | - | 60.4 | 63.7 | 71.1 | - | 29.2 | 29.6 | 60.9 | - | 57.7 | 55.5 | 63.1 | 60.7 | 63.5 | 68.7 | 60.5 | 54.9 | 62.3 | 68.8 | 74.0 | 61.4 | 97.3 | 94.0 | 85.9 | - | 79.4 | 120.7 | 117.8 | - | - | - | - | - | - | - | - | - | 119.6 | 49.3 | 112.2 | - | 2533.9 | - | - | - | 16.0 | 27.7 | 48.5 | - | 79.4 | 113.9 | - |
DIO |
675.7 | 571.3 | - | 496.9 | 392.4 | 334.0 | - | 45.1 | 135.4 | 307.8 | - | 180.1 | 233.5 | 267.6 | - | 212.5 | 267.3 | 233.9 | - | 229.0 | 238.7 | 252.4 | - | 177.6 | 244.2 | 227.0 | - | 235.7 | 397.6 | 473.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
156.5 | 191.1 | - | 168.2 | 192.7 | 265.4 | - | 40.9 | 127.5 | 267.3 | - | 149.2 | 162.6 | 231.5 | - | 185.4 | 233.2 | 270.1 | - | 354.2 | 369.3 | 318.7 | - | - | - | 137.3 | - | - | - | 759.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
734.8 | 633.6 | - | 557.3 | 456.1 | 405.1 | - | 74.3 | 165.0 | 368.7 | - | 237.8 | 289.0 | 330.7 | 60.7 | 275.9 | 336.0 | 294.4 | 54.9 | 291.2 | 307.6 | 326.4 | 61.4 | 274.9 | 338.3 | 312.9 | - | 315.1 | 518.2 | 591.1 | - | - | - | - | - | - | - | - | - | 119.6 | 49.3 | 112.2 | - | 2533.9 | - | - | - | 16.0 | 27.7 | 48.5 | - | 79.4 | 113.9 | - |
Cash Conversion Cycle |
578.3 | 442.4 | - | 389.1 | 263.4 | 139.7 | - | 33.4 | 37.5 | 101.3 | - | 88.6 | 126.3 | 99.3 | 60.7 | 90.6 | 102.8 | 24.3 | 54.9 | -63.0 | -61.8 | 7.7 | 61.4 | 274.9 | 338.3 | 175.7 | - | 315.1 | 518.2 | -168.6 | - | - | - | - | - | - | - | - | - | 119.6 | 49.3 | 112.2 | - | 2533.9 | - | - | - | 16.0 | 27.7 | 48.5 | - | 79.4 | 113.9 | - |
All numbers in USD currency